
Jan 28 (Reuters) - CalciMedica Inc CALC.O:
CALCIMEDICA ANNOUNCES DISCONTINUATION OF PHASE 2 KOURAGE TRIAL IN AKI FOLLOWING INDEPENDENT DATA MONITORING COMMITTEE RECOMMENDATION
CALCIMEDICA INC: SAFETY CONCERN WARRANTS REEVALUATION OF STUDY DESIGN, INCLUDING ENROLLMENT CRITERIA
CALCIMEDICA INC: POTENTIAL FUTURE TRIAL WITH AUXORA IN AKI TO BE EVALUATED AFTER DATA ANALYSIS
CALCIMEDICA INC - IDMC IDENTIFIES SAFETY CONCERN IN STUDY DESIGN
CALCIMEDICA INC: THERE WERE NO DEATHS IN TRIAL THAT WERE ASSESSED BY INVESTIGATORS OR CALCIMEDICA AS BEING RELATED TO STUDY DRUG